Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection

Background: Successful treatment of Helicobacter pylori infection results in cure of peptic ulcer disease. Multidrug regimens are needed to cure this infection. We studied the effectiveness and side effect profile of two antibiotics active against Helicobacter pylori, metronidazole and clarithromycin, combined with omeprazole.

[1]  F. Bazzoli,et al.  Effect of omeprazole and clarithromycin plus tinidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer , 1995 .

[2]  D. Graham,et al.  Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease. , 1994, The American journal of gastroenterology.

[3]  A. Mezzetti,et al.  Omeprazole, bismuth and clarithromycin in the sequential treatment of Helicobacter pylori infection , 1994, Alimentary pharmacology & therapeutics.

[4]  R. Genta,et al.  Clarithromycin‐amoxycillin therapy for Helicobacter pylori infection , 1994, Alimentary pharmacology & therapeutics.

[5]  D. Graham,et al.  Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection. , 1994, The American journal of gastroenterology.

[6]  Fred E. Silverstein,et al.  Helicobacter pylori in peptic ulcer disease. , 1994, NIH consensus statement.

[7]  R. Genta,et al.  Short Report: omeprazole‐tetracycline combinations are inadequate as therapy for Helicobacter pylori infection , 1994, Alimentary pharmacology & therapeutics.

[8]  D. Graham,et al.  Omeprazole as an adjuvant to antimicrobial therapy for eradication of Helicobacter pylori infection , 1994 .

[9]  D. Graham,et al.  Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain. , 1994, Human pathology.

[10]  J. H. Baron,et al.  Eradication of Helicobacter pylori with clarithromycin and omeprazole. , 1994, Gut.

[11]  C. O'Morain,et al.  Prevalence of metronidazole-resistant helicobacter pylori in dyspeptic patients , 1993, Irish journal of medical science.

[12]  D. Graham,et al.  THE ROLE OF INFECTIOUS AGENTS IN PEPTIC ULCER DISEASE , 1993 .

[13]  M. Walker,et al.  Clarithromycin and omeprazole for Helicobacter pylori , 1992, The Lancet.

[14]  J. Weil,et al.  Helicobacter pylori and metronidazole resistance , 1990, The Lancet.

[15]  V. Alvisi,et al.  Sydney classification for gastritis and Helicobacter pylori , 1990, The Lancet.

[16]  D. Graham,et al.  The who's and when's of therapy for Helicobacter pylori. , 1990, The American journal of gastroenterology.

[17]  A. Burette,et al.  Drug therapy for Helicobacter pylori infection: problems and pitfalls. , 1990, The American journal of gastroenterology.

[18]  A. Morden,et al.  Helicobacter pylori infection treated with a tripotassium dicitrato bismuthate and metronidazole combination , 1990, Alimentary pharmacology & therapeutics.

[19]  C. O'Morain,et al.  Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate. , 1990, Gut.

[20]  D. Vos,et al.  Metronidazole resistance in Helicobacter pylori , 1990, The Lancet.

[21]  A. Janssen,et al.  Metronidazole-resistant Helicobacter pylori , 1990, The Lancet.

[22]  K. Hanada,et al.  The Susceptibility of Campylobacter pylori to Antiulcer Agents and Antibiotics , 1990, Journal of clinical gastroenterology.

[23]  D. Graham,et al.  In vivo susceptibility of Campylobacter pylori. , 1989, The American journal of gastroenterology.

[24]  P. Fernandes,et al.  Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones. , 1988, The Journal of antimicrobial chemotherapy.